Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance?
Open Access
- 31 October 1996
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 28 (4) , 535-540
- https://doi.org/10.1016/s0272-6386(96)90464-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Enalapril treatment of posttransplant erythrocytosis: efficacy independent of circulating erythropoietin levelsAmerican Journal of Kidney Diseases, 1995
- CORRECTION OF POSTTRANSPLANT ERYTHROCYTOSIS WITH ENALAPRILTransplantation, 1994
- THE BENEFICIAL EFFECT OF ENALAPRIL ON ERYTHROCYTOSIS AFTER RENAL TRANSPLANTATIONTransplantation, 1993
- Enalapril-Associated Anemia in Renal Transplant Recipients Treated for HypertensionAmerican Journal of Kidney Diseases, 1991
- Angiotensin-Converting Enzyme Inhibitor and Anemia in a Patient Undergoing HemodialysisNephron, 1991
- Captopril induces correction of postrenal transplant erythremiaTransplant International, 1990
- Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathyScandinavian Journal of Clinical and Laboratory Investigation, 1990
- Worsening of Anemia by Angiotensin Converting Enzyme Inhibitors and Its Prevention by Antiestrogenic Steroid in Chronic Hemodialysis PatientsJournal of Cardiovascular Pharmacology, 1989
- Worsening of Anemia Induced by Long-Term Use of Captopril in Hemodialysis PatientsAmerican Journal of Nephrology, 1984